Reorganization of substance use treatment and harm reduction services during the COVID-19 pandemic: a global survey

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Radfar, Seyed Ramin
• dc.contributor.author De Jong, Cornelis A. J.
• dc.contributor.author Farhoudian, Ali
• dc.contributor.author Ebrahimi, Mohsen
• dc.contributor.author Rafei, Parnian
• dc.contributor.author Vahidi, Mehrnoosh
• dc.contributor.author Yunesian, Masud
• dc.contributor.author Kouimtsidis, Christos
• dc.contributor.author Arunogiri, Shalini
• dc.contributor.author Massah, Omid
• dc.contributor.author Deylamizadeh, Abbas
• dc.contributor.author Brady, Kathleen T.
• dc.contributor.author Busse, Anja
• dc.contributor.author ISAM-PPIG Global Survey Consortium
• dc.contributor.author Potenza, Marc N.
• dc.contributor.author Ekhtiari, Hamed
• dc.contributor.author Baldacchino, Alexander Mario
• dc.date.accessioned 2022-02-23T07:32:30Z
• dc.date.available 2022-02-23T07:32:30Z
• dc.date.issued 2021
• dc.description.abstract Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health responses were categorized around (1) managerial measures and systems, (2) logistics, (3) service providers, and (4) vulnerable groups. Results: Respondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. Fifty-seven percent of overdose prevention interventions and 81% of outreach services were also negatively impacted. Conclusions: Participants reported that SUD treatment and harm-reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we highlight several issues and complications resulting from the pandemic concerning people with SUDs that should be tackled more efficiently during the future waves or similar pandemics. The issues and potential strategies comprise the following: (1) helping policymakers to generate business continuity plans, (2) maintaining the use of evidence-based interventions for people with SUDs, (3) being prepared for adequate medication supplies, (4) integrating harm reduction programs with other treatment modalities, and (5) having specific considerations for vulnerable groups such as immigrants and refugees.
• dc.format.mimetype application/pdf
• dc.identifier.citation Radfar SR, De Jong CAJ, Farhoudian A, Ebrahimi M, Rafei P, Vahidi M, Yunesian M, Kouimtsidis C, Arunogiri S, Massah O, Deylamizadeh A, Brady KT, Busse A; ISAM-PPIG Global Survey Consortium, Potenza MN, Ekhtiari H, Baldacchino AM. Reorganization of substance use treatment and harm reduction services during the COVID-19 pandemic: a global survey. Front Psychiatry. 2021 Apr 29;12:639393. DOI: 10.3389/fpsyt.2021.639393
• dc.identifier.doi http://dx.doi.org/10.3389/fpsyt.2021.639393
• dc.identifier.issn 1664-0640
• dc.identifier.uri http://hdl.handle.net/10230/52545
• dc.language.iso eng
• dc.publisher Frontiers
• dc.relation.ispartof Front Psychiatry. 2021 Apr 29;12:639393
• dc.rights © 2021 Radfar, De Jong, Farhoudian, Ebrahimi, Rafei, Vahidi, Yunesian, Kouimtsidis, Arunogiri, Massah, Deylamizadeh, Brady, Busse, ISAM-PPIG Global Survey Consortium, Potenza, Ekhtiari and Baldacchino. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by/4.0/
• dc.subject.keyword COVID-19 pandemic
• dc.subject.keyword Addiction services
• dc.subject.keyword Drug policy
• dc.subject.keyword Harm reduction
• dc.subject.keyword Opioid agonist treatment
• dc.subject.keyword Public health
• dc.subject.keyword Substance use disorder
• dc.title Reorganization of substance use treatment and harm reduction services during the COVID-19 pandemic: a global survey
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion